INTERNATIONAL ENDORSEMENTS
International Endorsements
& Scientific Recognition
Independent validation from regulators, research institutions,
scientific publications and international healthcare organisations
supporting the development of MTL-004.
Award Winning Innovation
Recognised by leading organisations for our breakthrough science.
US Orphan Drug Designation
Official recognition supporting the development of MTL-004 in glioma.
Published Research 2024-2025
Pre-clinical studies presented and published in leading scientific forums.
MHRA Scientific Review
Positive scientific review supporting clinical trial progression.
ENDORSED BY LEADING ORGANISATIONS
